ATCH vs HIVE
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 12, 2026
ATCH
41.4
AI Score
VS
HIVE Wins
HIVE
65.2
AI Score
Investment Advisor Scores
HIVE
65score
Recommendation
BUY
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | ATCH | HIVE | Winner |
|---|---|---|---|
| Revenue | 13.51M | 164.00M | HIVE |
| Net Income | 4.41M | -221.61M | ATCH |
| Net Margin | 32.7% | -135.1% | ATCH |
| ROE | 19.8% | -60.8% | ATCH |
| ROA | 6.0% | -25.8% | ATCH |
| Total Assets | 73.92M | 857.69M | HIVE |
| Cash | 16.71M | 138.99M | HIVE |
| Current Ratio | 1.52 | 1.55 | HIVE |
Relative Price Performance (Last 90 Days)
ATCH 1M: -49.8%
· 3M: -56.7%
HIVE 1M: -26.2%
· 3M: -32.2%
Current Technical Phase
ATCH
MarkdownSell / avoid
Price below a falling SMA50 (slope -9.1%), weak momentum, RSI 18
HIVE
MarkdownSell / avoid
Price below a falling SMA50 (slope -12.6%), weak momentum, RSI 36
Fundamentals Snapshot
| Metric | ATCH | HIVE |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -1.4 | -3.4 |
| Trailing P/E | 6.6 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 1.4% | 0.7% |
| Gross Margin | 0.7% | 0.4% |
| Operating Margin | -0.4% | -0.6% |
| EPS | 0.02 | -1.53 |
| Dividend Yield | — | — |
Frequently Asked Questions
Based on our detailed analysis, HIVE is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.